{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:31:00Z","timestamp":1791945060473,"version":"4.3.4"},"reference-count":52,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2017,1,15]],"date-time":"2017-01-15T00:00:00Z","timestamp":1484438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100011029","name":"Helmholtz Alberta Initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011029","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2017,1,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Chronic hepatitis C virus (HCV) infection causes severe liver disease and affects ca. 146 million individuals. Novel directly acting antivirals targeting HCV have revolutionized treatment. However, high costs limit access to therapy. Recently, several related drugs used in humans to treat allergies or as neuroleptics emerged as potent HCV cell entry inhibitors. Insights into their antiviral modes of action may increase opportunities for drug repurposing in hepatitis C and possibly other important human viral infections.<\/jats:p>","DOI":"10.1128\/jvi.01914-16","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T01:23:24Z","timestamp":1478136204000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":23,"title":["Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases"],"prefix":"10.1128","volume":"91","author":[{"given":"Thomas","family":"Pietschmann","sequence":"first","affiliation":[{"name":"Institute for Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, and German Centre for Infection Research, Hannover-Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.006"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912966107"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0915117107"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010286"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28111"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07684"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-016-9724-7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00024-06"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02460-05"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.4.1734-1741.2006"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009512"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3179"},{"key":"e_1_3_2_16_2","first-page":"209","article-title":"Influence of chlorpromazine on the replication of influenza virus in chick embryo cells","volume":"26","author":"Krizanova O","year":"1982","unstructured":"Krizanova O Ciampor F Veber P . 1982. Influence of chlorpromazine on the replication of influenza virus in chick embryo cells. Acta Virol26:209\u2013216.","journal-title":"Acta Virol"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.15.4955"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(96)06956-2"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(83)90116-2"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1994.10.1489"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(99)00158-2"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02593-12"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.06.014"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(91)90032-M"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962010000200010"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(24)01328-0","article-title":"International Union of Pharmacology. XIII. Classification of histamine receptors","volume":"49","author":"Hill SJ","year":"1997","unstructured":"Hill SJ Ganellin CR Timmerman H Schwartz JC Shankley NP Young JM Schunack W Levi R Haas HL . 1997. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev49:253\u2013278.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08144"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd913"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature19107"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2199"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep28288"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.115.099663"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10236"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1178"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10361"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.5"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1988.tb33413.x"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1988.tb33414.x"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.24.13001-13014.2002"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2015.23"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.75.1.144"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0026-895X(25)08923-0","article-title":"Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines","volume":"42","author":"Enyeart JJ","year":"1992","unstructured":"Enyeart JJ Biagi BA Mlinar B . 1992. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines. Mol Pharmacol42:364\u2013372.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1988.sp016916"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(82)90232-X"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.91.3.798"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.123.5.1107"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(90)90297-2"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02882-12"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010026107"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021756"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0832180100"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02094-13"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01914-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01914-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:35:38Z","timestamp":1749684938000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01914-16"}},"subtitle":[],"editor":[{"given":"Michaela Ulrike","family":"Gack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,15]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1,15]]}},"alternative-id":["10.1128\/JVI.01914-16"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01914-16","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,15]]},"assertion":[{"value":"2017-01-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01914-16"}}